Chronic heart allograft rejection in rats demonstrates a dynamic interplay between IFN-γ and IL-10 producing T cells

Transplant Immunology

Volumn 13, Issue 3, 2004, Pages 201-209

  Köksoy, Sadi ^a   Kakoulidis, Thanos P ^a   Shirwan, Haval ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Chronic rejection; Direct indirect pathways; IFN ; IL 10; T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNE RESPONSE; LYMPHOCYTE; MALE; NONHUMAN; ORGAN DONOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION; GRAFT REJECTION; HEART TRANSPLANTATION; INTERFERON TYPE II; INTERLEUKIN-10; LYMPHOCYTE CULTURE TEST, MIXED; MODELS, ANIMAL; RATS; RATS, INBRED STRAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 4644229487     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2004.03.001     Document Type: Article

References (36)

1. Shirwan H. Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role? Transplantation. 68:(6):1999;715-726
2. Libby P., Pober J.S. Chronic rejection. Immunity. 14:(4):2001;387-397
3. Shirwan H., Leamer M., Wang H.K., Makowka L., Cramer D.V. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Transplantation. 59:(3):1995;401-410
4. Ciubotariu R., Liu Z., Colovai A.I., Ho E., Itescu S., Ravalli S., et al. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest. 101:(2):1998;398-405
5. Lee R.S., Yamada K., Houser S.L., Womer K.L., Maloney M.E., Rose H.S., et al. Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc Natl Acad Sci USA. 98:(6):2001;3276-3281
6. Raisanen-Sokolowski A., Mottram P.L., Glysing-Jensen T., Satoskar A., Russell M.E. Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection. J Clin Invest. 100:(10):1997;2449-2456
7. Raisanen-Sokolowski A., Glysing-Jensen T., Russell M.E. Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice. Am J Pathol. 153:(5):1998;1491-1500
8. Qin L., Chavin K.D., Ding Y., Tahara H., Favaro J.P., Woodward J.E., et al. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol. 156:(6):1996;2316-2323
9. Le Moine A., Goldman M., Abramowicz D. Multiple pathways to allograft rejection. Transplantation. 73:(9):2002;1373-1381
10. Le Moine A., Flamand V., Demoor F.X., Noel J.C., Surquin M., Kiss R., et al. Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection. J Clin Invest. 103:(12):1999;1659-1667
11. Hayashi M., Martinez O.M., Garcia-Kennedy R., So S., Esquivel C.O., Krams S.M. Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation. 60:(12):1995;1533-1538
12. Orosz C.G., Wakely E., Sedmak D.D., Bergese S.D., VanBuskirk A.M. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate vs. anti-CD4 monoclonal antibody. Transplantation. 63:(8):1997;1109-1117
13. Nagano H., Mitchell R.N., Taylor M.K., Hasegawa S., Tilney N.L., Libby P. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest. 100:(3):1997;550-557
14. Russell M.E., Wallace A.F., Hancock W.W., Sayegh M.H., Adams D.H., Sibinga N.E., et al. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation. 59:(4):1995;572-578
15. Tellides G., Tereb D.A., Kirkiles-Smith N.C., Kim R.W., Wilson J.H., Schechner J.S., et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature. 403:(6766):2000;207-211
16. Fischbein M.P., Yun J., Laks H., Irie Y., Fishbein M.C., Bonavida B., et al. Role of CD8+ lymphocytes in chronic rejection of transplanted hearts. J Thorac Cardiovasc Surg. 123:(4):2002;803-809
17. Ardehali A., Fischbein M.P., Yun J., Irie Y., Fishbein M.C., Laks H. Indirect alloreactivity and chronic rejection. Transplantation. 73:(11):2002;1805-1807
18. Shirwan H., Mhoyan A., Yolcu E.S., Que X., Ibrahim S. Chronic cardiac allograft rejection in a rat model disparate for one single class I MHC molecule is associated with indirect recognition by CD4(+) T cells. Transpl Immunol. 11:(2):2003;179-185
19. Gallico G.G., Butcher G.W., Howard J.C. The role of subregions of the rat major histocompatibility complex in the rejection and passive enhancement of renal allografts. J Exp Med. 149:(1):1979;244-253
20. Howard J.C., Butcher G.W., Galfre G., Milstein C., Milstein C.P. Monoclonal antibodies as tools to analyze the serological and genetic complexities of major transplantation antigens. Immunol Rev. 47:1979;139-174
21. Gracie J.A., Bolton E.M., Porteous C., Bradley J.A. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity. J Exp Med. 172:(6):1990;1547-1557
22. Biedermann B.C., Pober J.S. Human endothelial cells induce and regulate cytolytic T cell differentiation. J Immunol. 161:(9):1998;4679-4687
23. Kreisel D., Krupnick A.S., Gelman A.E., Engels F.H., Popma S.H., Krasinskas A.M., et al. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat Med. 8:(3):2002;233-239
24. Suchin E.J., Langmuir P.B., Palmer E., Sayegh M.H., Wells A.D., Turka L.A. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol. 166:(2):2001;973-981
25. Gilot B.J., Hara M., Jones N.D., van Maurik A., Niimi M., Hadjianastassiou V., et al. Visualization of the in vivo generation of donor antigen-specific effector CD8+ T cells during mouse cardiac allograft rejection: in vivo effector CD8+ T cell generation during allograft rejection. Transplantation. 69:(4):2000;639-648
26. Shirwan H., Barwari L., Khan N.S. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides. Transplantation. 66:(12):1998;1802-1809
27. Lee R.S., Grusby M.J., Glimcher L.H., Winn H.J., Auchincloss H. Jr. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med. 179:(3):1994;865-872
28. Illigens B.M., Yamada A., Fedoseyeva E.V., Anosova N., Boisgerault F., Valujskikh A., et al. The relative contribution of direct and indirect antigen recognition pathways to the alloresponse and graft rejection depends upon the nature of the transplant. Hum Immunol. 63:(10):2002;912-925
29. Shirwan H., Mhoyan A., Kakoulidis T.P., Yolcu E.S., Ibrahim S. Prevention of chronic rejection with immunoregulatory cells induced by intrathymic immune modulation with class I allopeptides. Am J Transpl. 3:(5):2003;581-589
30. Zhang Q.W., Tomita Y., Matsuzaki G., Uchida T., Yoshikawa M., Nakashima Y., et al. Chronic rejection in H-2 matched cardiac allografts: early emergence of vasculopathy, alloantibody, and accumulation of IFN-gamma and IL-10 mRNA. Transpl Int. 14:(3):2001;143-152
31. Joosten S.A., Van Kooten C., Paul L.C. Pathogenesis of chronic allograft rejection. Transpl Int. 16:(3):2003;137-145
32. Yamada A., Laufer T.M., Gerth A.J., Chase C.M., Colvin R.B., Russell P.S., et al. Further analysis of the T-cell subsets and pathways of murine cardiac allograft rejection. Am J Transpl. 3:(1):2003;23-27
33. Szeto W.Y., Krasinskas A.M., Kreisel D., Krupnick A.S., Popma S.H., Rosengard B.R. Depletion of recipient CD4+ but not CD8+ T lymphocytes prevents the development of cardiac allograft vasculopathy. Transplantation. 73:(7):2002;1116-1122
34. Furukawa Y., Becker G., Stinn J.L., Shimizu K., Libby P., Mitchell R.N. Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol. 155:(6):1999;1929-1939
35. Wang L., Goillot E., Tepper R.I. IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo. Cell Immunol. 159:(2):1994;152-169
36. Blander J.M., Sant'Angelo D.B., Bottomly K., Janeway C.A. Jr. Alteration at a single amino acid residue in the T cell receptor alpha chain complementarity determining region 2 changes the differentiation of naive CD4 T cells in response to antigen from T helper cell type 1 (Th1) to Th2. J Exp Med. 191:(12):2000;2065-2074